[HTML][HTML] Modulation of intracellular copper levels as the mechanism of action of anticancer copper complexes: Clinical relevance
Copper (Cu) is a vital element required for cellular growth and development; however, even
slight changes in its homeostasis might lead to severe toxicity and deleterious medical …
slight changes in its homeostasis might lead to severe toxicity and deleterious medical …
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
A Hybrid drug which comprises the incorporation of two drug pharmacophores in one single
molecule are basically designed to interact with multiple targets or to amplify its effect …
molecule are basically designed to interact with multiple targets or to amplify its effect …
Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
GL Beretta, G Cassinelli, M Pennati, V Zuco… - European journal of …, 2017 - Elsevier
Resistance to conventional and target specific antitumor drugs still remains one of the major
cause of treatment failure and patience death. This condition often involves ATP-binding …
cause of treatment failure and patience death. This condition often involves ATP-binding …
[HTML][HTML] Metal-and metalloid-based compounds to target and reverse cancer multidrug resistance
Drug resistance remains the major cause of cancer treatment failure especially at the late
stage of the disease. However, based on their versatile chemistry, metal and metalloid …
stage of the disease. However, based on their versatile chemistry, metal and metalloid …
Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition
KM Hanssen, M Haber, JI Fletcher - Drug Resistance Updates, 2021 - Elsevier
Resistance to chemotherapy remains one of the most significant obstacles to successful
cancer treatment. While inhibiting drug efflux mediated by ATP-binding cassette (ABC) …
cancer treatment. While inhibiting drug efflux mediated by ATP-binding cassette (ABC) …
Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands
The small molecule anticancer agent cisplatin and its Pt (II) analogs carboplatin and
oxaliplatin are widely used to treat a variety of tumorigenic diseases. Despite their structural …
oxaliplatin are widely used to treat a variety of tumorigenic diseases. Despite their structural …
Anticancer thiosemicarbazones: chemical properties, interaction with iron metabolism, and resistance development
FS PapeVeronika, A EnyedyÉva… - Antioxidants & redox …, 2019 - liebertpub.com
Significance: During the past decades, thiosemicarbazones were clinically developed for a
variety of diseases, including tuberculosis, viral infections, malaria, and cancer. With regard …
variety of diseases, including tuberculosis, viral infections, malaria, and cancer. With regard …
Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and Future
SPC Cole - Annual review of pharmacology and toxicology, 2014 - annualreviews.org
The human ATP-binding cassette transporter multidrug resistance protein 1 (MRP1),
encoded by ABCC1, was initially identified because of its ability to confer multidrug …
encoded by ABCC1, was initially identified because of its ability to confer multidrug …
Collateral sensitivity as a strategy against cancer multidrug resistance
KM Pluchino, MD Hall, AS Goldsborough… - Drug Resistance …, 2012 - Elsevier
While chemotherapy remains the most effective treatment for disseminated tumors, acquired
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …
[HTML][HTML] Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance
G Szakács, MD Hall, MM Gottesman… - Chemical …, 2014 - ACS Publications
The development of multidrug resistance (MDR) in patients suffering cancer remains a
significant clinical challenge, with drug efflux by ABC (ATP-binding cassette) transporters …
significant clinical challenge, with drug efflux by ABC (ATP-binding cassette) transporters …